Beyond HMAs: Novel Targets and Therapeutic Approaches

Getz, Ted M.; Bewersdorf, Jan P.; Kewan, Tariq; Stempel, Jessica M.; Bidikian, Aram; Shallis, Rory M.; Stahl, Maximilian; Zeidan, Amer M.

doi:10.1053/j.seminhematol.2024.08.001

Seminars in Hematology

2024

DOI: 10.1053/j.seminhematol.2024.08.001

|View full text |Cite

Beyond HMAs: Novel Targets and Therapeutic Approaches

Ted M. Getz,

Jan P. Bewersdorf,

Tariq Kewan

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

References 136 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

A Call to Arms: Overcoming challenges in Myelodysplastic Syndromes therapy advances

McGraw,

Aplan,

Pavletic

2024

Seminars in Hematology

View full text Add to dashboard Cite

A Call to Arms: Overcoming challenges in Myelodysplastic Syndromes therapy advances

McGraw,

Aplan,

Pavletic

2024

Seminars in Hematology

View full text Add to dashboard Cite

Acute Myeloid Leukemia in Older Patients: From New Biological Insights to Targeted Therapies

Niscola,

Gianfelici,

Catalano

et al. 2024

Current Oncology

View full text Add to dashboard Cite

Acute myeloid leukemia (AML) is a heterogeneous blood-related neoplasm that predominantly afflicts older adults with a poor prognosis due to their physical condition and the presence of medical accompanying comorbidities, adverse biological disease features, and suitability for induction intensive chemotherapy and allogenic stem cells transplantation. Recent research into the molecular and biological factors contributing to disease development and progression has led to significant advancements in treatment approaches for older patients with AML. This review article discusses the latest biological and therapeutic developments that are transforming the management of AML in older adults.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Beyond HMAs: Novel Targets and Therapeutic Approaches

Cited by 2 publications

References 136 publications

A Call to Arms: Overcoming challenges in Myelodysplastic Syndromes therapy advances

A Call to Arms: Overcoming challenges in Myelodysplastic Syndromes therapy advances

Acute Myeloid Leukemia in Older Patients: From New Biological Insights to Targeted Therapies

Contact Info

Product

Resources

About